Bacil Pharma Ltd — Board Meeting, 13-02-2026: Board Meeting
13-02-2026 | 02:14 pm
13-02-2026 | 02:14 pm
Bacil Pharma's Board approved Q3FY26 & 9M financial results. Q3 net profit was ₹0.06 Cr, while 9M net profit stood at ₹0.80 Cr. EPS for Q3 was ₹0.03 and ₹0.52 for 9M.
No comments yet. Be the first to comment!
